Site icon pharmaceutical daily

H2 2020 Pipeline Review for Cerebral Palsy – Snapshot of the Global Therapeutic Landscape – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Cerebral Palsy – Pipeline Review, H2 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering.

The publisher’s latest Pharmaceutical and Healthcare disease pipeline guide provides an overview of the Cerebral Palsy (Central Nervous System) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Cerebral Palsy (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Cerebral Palsy (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Cerebral Palsy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 2, 1, 1, 7, 1 and 1 respectively. Similarly, the Universities portfolio in Phase 0 and Preclinical stages comprises 1 and 1 molecules, respectively.

Cerebral Palsy (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the publisher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope

Reasons to Buy

Key Topics Covered:

1. Introduction

2. Cerebral Palsy – Overview

3. Cerebral Palsy – Therapeutics Development

4. Cerebral Palsy – Therapeutics Assessment

5. Cerebral Palsy – Companies Involved in Therapeutics Development

6. Cerebral Palsy – Drug Profiles

7. Cerebral Palsy – Dormant Projects

8. Cerebral Palsy – Product Development Milestones

9. Appendix

For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/rqfedh

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Exit mobile version